However, for generic drug makers, which are hardest hit by Chinese tariffs, slim profit margins and high costs may thwart ...

Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

LGM Pharma is investing over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its Phase I CDMO ...

Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the ...

ABUJA, NIGERIA / ACCESS Newswire / March 11, 2025 / In a landmark effort to transform Nigeria's pharmaceutical industry and ...

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...